New HRS Drug Cuts Need for Renal Replacement Tx After Liver Transplant

(MedPage Today) -- Terlipressin (Terlivaz) reduced the need for renal replacement therapy (RRT) in patients with type 1 hepatorenal syndrome (HRS) who underwent liver transplant, extended follow-up of the phase III CONFIRM trial showed. In the...
Source: MedPage Today Surgery - Category: Surgery Source Type: news